Overview of Disease Management

Timothy Myers MBA RRT-NPS FAARC , Irving TX

This presentation will identify the key components to a comprehensive disease management program and discuss the necessary skills of an effective disease manager.

Speaker sponsored by

Pathophysiology and Assessment of COPD

Richard H Casaburi MD MEng PhD, Torrance CA

This presentation will discuss the pathophysiology, diagnosis, treatment strategies, and assessment components of COPD.

Recommended resource for this session: Global Strategy for Diagnosis, Management, and Prevention of COPD (2015)

Speaker sponsored by

Break

Pathophysiology and Assessment of Pulmonary Fibrosis

Trina M Limberg BS RRT FAARC MAACVPR, San Diego CA

This presentation will discuss the pathophysiology, diagnosis, treatment strategies, and assessment components of pulmonary fibrosis.

Recommended resource for this session: An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-Based Guidelines for Diagnosis and Management (2011) )

Speaker sponsored by

Pathophysiology and Assessment of Asthma

Bradley E Chipps MD, Sacramento CA

This presentation will discuss the pathophysiology, diagnosis, treatment strategies, and assessment components of asthma.

Recommended resource for this session: NHLBI NAEPP Expert Panel 3: Guidelines for the Diagnosis and Management of Asthma (2007)

Speaker sponsored by

Lunch Provided

Pathophysiology and Assessment of Pulmonary Hypertension

Shawna L Strickland PhD RRT-NPS RRT-ACCS FAARC, Irving TX

This presentation will discuss the pathophysiology, diagnosis, treatment strategies, and assessment components of pulmonary hypertension.

Recommended resource for this session: Pharmacologic Therapy for Pulmonary Arterial Hypertension in Adults: CHEST Guideline and Expert Panel Report (2014)

Speaker sponsored by

Pathophysiology and Assessment of Cystic Fibrosis

Dabney M Eidson BS RRT-NPS, Augusta GA

This presentation will discuss the pathophysiology, diagnosis, treatment strategies, and assessment components of Cystic Fibrosis.

Recommended resource for this session: Cystic Fibrosis Pulmonary Guidelines: Chronic Medication for Maintenance of Lung Health (2013)

Speaker sponsored by

Break

Pulmonary Function Testing

Curt Merriman BA RRT CPFT, Burnsville MN

This presentation will assist the participant in differentiating the various types of pulmonary function tests and their use among the disease processes discussed in the course as well as identifying disease severity based on pulmonary function test results.

Recommended resource for this session: ATS/ERS Standards for Pulmonary Function Testing

Speaker sponsored by

Pharmacologic Interventions

Sarah L Varekojis PhD RRT, Westerville OH

This presentation will discuss currently available pulmonary medications and their indications, delivery methods, and medication interaction.

Recommended resource for this session: AARC Guide to Aerosol Delivery Devices for Respiratory Therapists, 3rd Edition (2013)

Speaker sponsored by

Supplemental Oxygen Administration

Thomas J Kallstrom MBA RRT FAARC, Irving TX

This presentation will describe the physiologic benefit of supplemental oxygen while also assisting the health care professional in differentiating between home systems and determining the appropriate delivery system to meet patient need.

Recommended resources for this session: AARC Clinical Practice Guideline: Oxygen Therapy in the Home or Alternative Site Health Care Facility (2007)

AARC Guide to Portable Oxygen Concentrators (2013)

Speaker sponsored by